September 19, 2021

Volume XI, Number 262

Advertisement

September 17, 2021

Subscribe to Latest Legal News and Analysis

September 16, 2021

Subscribe to Latest Legal News and Analysis

USPTO Extends Patent and Trademark Filing and Fee Deadlines Further in Response to COVID-19

Earlier this month, we provided posts here and here, outlining the United States Patent and Trademark Office’s (“USPTO”) announcement of the availability of certain deadline waivers to help patent and trademark applicants and owners file papers during the COVID-19 outbreak. The original notice granted a 30-day extension on certain deadlines falling between March 27 and April 30, 2020 (inclusive).

On April 28, in new notices, the USPTO extended that time period further for both patents and trademarks. Papers filed on or before June 1, with deadlines falling between March 27 and May 31, 2020 (inclusive), will be considered timely, provided the papers include a statement that the delay in filing was due to the COVID-19 outbreak. The USPTO’s interpretation of applicants’ reasons on how the COVID-19 outbreak delayed their filing appears to be unchanged, as do the 12 categories of extensions in the original notice.

Patents

The new patent notice is very similar to the original notice. Certain categories of available relief that were broken out separately before, now are identified as two of 14 categories of available relief falling within the March 27 – May 31 time frame. These are:

xiii. request for rehearing of a PTAB decision under 37 C.F.R. § 41.125(c) or 41.127(d); and.

xiv. petition to the Chief Judge under 37 C.F.R. § 41.3.

A 30-day extension for patent owner preliminary responses (“POPR”) in a trial proceeding, or any related responsive filings, where the due date fell between March 27 and April 30, 2020, still is available. As before, relief sought from a deadline coming after April 30 would not be automatic, and would have to come from the Patent Trial and Appeal Board (“PTAB”). Also as before, if the PTAB extends a POPR deadline, the PTAB also may extend statutory deadlines for institution of trial proceedings.[i]

The new USPTO notice incorporates guidance that the Office provided in March regarding petitions to revive. In applications and reexamination proceedings that were abandoned (or terminated or limited) on or before May 31, 2020, because of the COVID-19 outbreak, the USPTO will waive the revival petition fee.

Trademarks

The new trademark notice is virtually identical to the previous notice, except of course for the extension of the period for available relief. The new notice incorporates the Office’s March guidance regarding petitions to review for abandoned applications and canceled or expired registrations, extending the time frame for abandonments to May 31, 2020.

What’s Next?

Like many federal and state governmental agencies, the USPTO is taking incremental steps in response to the COVID-19 outbreak. It remains to be seen whether the Office will provide additional relief into the summer months.

[i] Ordinarily, the PTAB is required by law to determine within three months whether to institute a trial proceeding. 35 U.S.C. §§ 314(b) and 324(c).

© Copyright 2021 Squire Patton Boggs (US) LLPNational Law Review, Volume X, Number 120
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement

About this Author

Frank Bernstein Patent & Intellectual Property Attorney Squire Patton Boggs Palo Alto, CA
Partner

Frank Bernstein uses his extensive patent litigation experience to think outside the box, helping clients obtain and defend challenging patents. He has extensive experience before the US Patent and Trademark Office (both pre-grant and post-grant patent matters), as well as in US district courts in all phases of patent infringement actions (pre-filing investigations to claim construction, Markman hearings to trials and appeals). His high technology expertise includes computer hardware and software, electronics, semiconductors, wireless, e-commerce and mechanical engineering. Apple, Sony,...

650-843-3337
Advertisement
Advertisement
Advertisement